Another retrospective study analyzed 78 postmenopausal stage I/II patients with BC treated with adjuvant TAM and found that patients with PTEN-negative BC had significantly shorter DFI and OS compared to PTEN-positive patients with BC [26]. This evidence concerns the gene PTEN and breast cancer.